Quarterly report pursuant to Section 13 or 15(d)

Share based compensation - Summary of stock option activity (Details)

v3.21.2
Share based compensation - Summary of stock option activity (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jul. 27, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Number of shares            
Outstanding at the beginning   2,919,493   2,414,303 2,414,303  
Granted       210,800    
Exercised (1,833,596)          
Forfeited       (198,400)    
Outstanding at the end     2,919,493     2,414,303
Weighted average exercise price            
Outstanding at the beginning (in dollars per share)   $ 5.25   $ 2.17 $ 2.17  
Granted (in dollars per share)       11.69    
Forfeited (in dollars per share)       $ (2.22)    
Outstanding at the end (in dollars per share)     $ 5.25     $ 2.17
Weighted average remaining remaining term (in years)            
Outstanding     9 years     8 years 2 months 12 days
Granted (in years)       9 years 9 months 18 days    
Aggregate intrinsic value            
Outstanding at the beginning (in dollars)   $ 20,558,299   $ 53,659,966 $ 53,659,966  
Granted (in dollars)       3,825,276    
Forfeited       $ (6,587,328)    
Outstanding at the end (in dollars)     $ 20,558,299     $ 53,659,966
2016 Omnibus Inventive Plan [Member]            
Number of shares            
Outstanding at the beginning     2,426,703      
Granted   82,890 587,030      
Exercised   (511,065) (4,960)      
Forfeited   (102,507) (89,280)      
Outstanding at the end   2,388,811   2,426,703 2,388,811  
Weighted average exercise price            
Outstanding at the beginning (in dollars per share)     $ 14.58      
Granted (in dollars per share)   $ 13.68 14.94      
Exercised (in dollars per share)   (2.22) (3.07)      
Forfeited (in dollars per share)   (3.07) $ (7.86)      
Outstanding at the end (in dollars per share)   $ 6.04   $ 14.58 $ 6.04  
Weighted average remaining remaining term (in years)            
Outstanding   8 years 1 month 6 days   8 years 8 months 12 days    
Granted (in years)   9 years 10 months 24 days 9 years 10 months 24 days      
Forfeited (in years)   0 years        
Exercised (in years)   0 years        
Aggregate intrinsic value            
Outstanding at the beginning (in dollars)     $ 30,388,510      
Exercised (in dollars)   $ (3,602,645) (42,385)      
Forfeited   (635,543) $ (339,082)      
Outstanding at the end (in dollars)   $ 12,447,723   $ 30,388,510 $ 12,447,723  
2021 Omnibus Incentive Plan            
Number of shares            
Options vested and exercisable   1,250,340     1,250,340  
Weighted average exercise price            
Options vested and exercisable   $ 1.86     $ 1.86  
Weighted average remaining remaining term (in years)            
Options vested and exercisable   6 years 2 months 12 days        
Aggregate intrinsic value            
Options vested and exercisable   $ 9,418,169     $ 9,418,169  
As previously reported            
Number of shares            
Outstanding at the beginning (as previously reported)           486,755
Weighted average exercise price            
Outstanding at the beginning (as previously reported)           $ 10.79
Weighted average remaining remaining term (in years)            
Outstanding at the beginning (as previously reported) (in years)           8 years 9 months 18 days
Aggregate intrinsic value            
Outstanding at the beginning (as previously reported) (in dollars)           $ 19,571,655
Retroactive application of reverse recapitalization            
Number of shares            
Retroactive application of reverse recapitalization           1,927,548
Weighted average exercise price            
Retroactive application of reverse recapitalization           $ (8.62)